[Modified bortezomib-based combination therapy for multiple myeloma]

Zhonghua Xue Ye Xue Za Zhi. 2014 Sep;35(9):854-6. doi: 10.3760/cma.j.issn.0253-2727.2014.09.017.

[Article in Chinese]

Authors

Daolin Wei¹, Chuxian Zhao¹, Min Zhao¹, Ju Wei¹, Yanrong Gao¹, Qi Cai¹, Chun Wang¹

Affiliation

¹ Department of hematology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, China.

PMID: 25246260
DOI: 10.3760/cma.j.issn.0253-2727.2014.09.017

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Boronic Acids / administration & dosage*
Bortezomib
Humans
Multiple Myeloma / drug therapy*
Pyrazines / administration & dosage*

Substances

Boronic Acids
Pyrazines
Bortezomib